Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 5, 2008, Pages 535-541

  Wang, Hui ^a   Pan, Ke ^a   Zhang, Hua Kun ^a   Weng, De Sheng ^a   Zhou, Jun ^a   Li, Jian Jun ^a   Huang, Wei ^a   Song, Hai Feng ^a   Chen, Min Shan ^a   Xia, Jian Chuan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Bmi 1; Expression; Hepatocellular carcinoma; Immunohistochemical analysis; Prognosis

Indexed keywords

BMI1 PROTEIN;

ADULT; AGED; ARTICLE; BMI 1 GENE; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 41049109184     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0316-8     Document Type: Article

References (24)

1. Bosch FX, Ribes J, Cleries R, Diaz M (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191-211
2. Breuer RH, Snijders PJ, Smit EF, Sutedja TG, Sewalt RG, Otte AP, van Kemenade FJ, Postmus PE, Meijer CJ, Raaphorst FM (2004) Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia 6:736-743
3. Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y, Kimura A (2007) Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia 21:1116-1122
4. Cui H, Hu B, Li T, Ma J, Alam G, Gunning WT, Ding HF (2007) Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol 170:1370-1378
5. Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M, Campisi J, Wazer DE, Band V (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62:4736-4745
6. Haupt Y, Bath ML, Harris AW, Adams JM (1993) Bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene 8:3161-3164
7. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M (1999a) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164-168
8. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M (1999b) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13:2678-2690
9. Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, Christensen R, Han T, Park NH (2007) Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 96:126-133
10. Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, Lee Y, Choe IS, Kim JW (2004a) Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 13:383-388
11. Kim JH, Yoon SY, Kim CN, Joo JH, Moon SK, Choe IS, Choe YK, Kim JW (2004b) The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 203:217-224
12. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907-1917
13. Mohty M, Yang AS, Szydlo RM, Apperley JF, Melo JV (2007) The polycomb group BMI-1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood 110:380-383
14. Neo SY, Leow CK, Vega VB, Long PM, Islam AF, Lai PB, Liu ET, Ren EC (2004) Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology 39:944-953
15. Okuda K (2000) Hepatocellular carcinoma. J Hepatol 32:225-237
16. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: globocan 2000. Int J Cancer 94:153-156
17. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX (2006) Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 66:6225-6232
18. Steele JC, Torr EE, Noakes KL, Kalk E, Moss PA, Reynolds GM, Hubscher SG, van Lohuizen M, Adams DH, Young LS (2006) The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens. Br J Cancer 95:1202-1211
19. Tateishi K, Ohta M, Kanai F, Guleng B, Tanaka Y, Asaoka Y, Tada M, Seto M, Jazag A, Lianjie L, Okamoto M, Isayama H, Tada M, Yoshida H, Kawabe T, Omata M (2006) Dysregulated expression of stem cell factor Bmi-1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res 12:6960-6966
20. Thomas MB, Zhu AX (2005) Hepatocellular carcinoma: the need for progress. J Clin Oncol 23:2892-2899
21. van Galen JC, Muris JJ, Oudejans JJ, Vos W, Giroth CP, Ossenkoppele GJ, Otte AP, Raaphorst FM, Meijer CJ (2007) Expression of the polycomb-group gene Bmi-1 is related to an unfavourable prognosis in primary nodal DLBCL. J Clin Pathol 60:167-172
22. van Leenders GJ, Dukers D, Hessels D, van den Kieboom SW, Hulsbergen CA, Witjes JA, Otte AP, Meijer CJ, Raaphorst FM (2007) Polycomb-group oncogenes EZH2, Bmi-1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur Urol 52:455-463
23. van Lohuizen M, Frasch M, Wientjens E, Berns A (1991) Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2. Nature 353:353-355
24. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC (2001) The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 84:1372-1376